Skip to main content
Signal8

Hill Stephen J.

SEC insider (Form 3/4/5 filer). CIK 0001866154. Chief Operating Officer at Lyell Immunopharma, Inc. (LYEL). 14 reported Form 4/5 transactions since Sep 2024; latest on Aug 21, 2026. Located in SOUTH SAN FRANCISCO, CA.

Companies Hill Stephen J. has filed insider reports for

  • Lyell Immunopharma, Inc. (LYEL): Officer, Chief Operating Officer
Hill Stephen J. profile photo

Hill Stephen J.

CIK: 0001866154

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (64.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (35.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lyell Immunopharma, Inc. logo
LYEL

Lyell Immunopharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Aug 21, 2026
    Sale
    Direct
    989 shares at avg. $15.54$15K
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Aug 10, 2026
    Sale
    Direct
    89 shares at avg. $14.34$1K
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    May 11, 2026
    Sale
    Direct
    89 shares at avg. $18.92$2K
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Feb 11, 2026
    Sale
    Direct
    1.2K shares at avg. $23.39$29K
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Feb 10, 2026
    Award

    Option (right to buy)

    Direct
    65K shares-
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Feb 10, 2026
    Sale
    Direct
    109 shares at avg. $23.12$3K
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Feb 9, 2026
    Award
    Direct
    4K shares-
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Nov 10, 2025
    Sale
    Direct
    95 shares at avg. $16.12$2K
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Oct 27, 2025
    Award

    Option (right to buy)

    Direct
    75K shares-
  • Lyell Immunopharma, Inc. logo
    LYEL

    Lyell Immunopharma, Inc.

    Aug 21, 2025
    Sale
    Direct
    1K shares at avg. $10.54$11K

1-10 of 14